Programmed cell death protein 1

Results: 66



#Item
1PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Jeffrey R. Infante1, Aung Naing2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish Patel1,8 ,

PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Jeffrey R. Infante1, Aung Naing2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish Patel1,8 ,

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2015-12-11 00:15:30
224 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

Add to Reading List

Source URL: www.nzma.org.nz

Language: English - Date: 2016-05-25 01:37:50
3Matanuska-­‐Susitna	
  Borough	
  School	
  District Midnight	
  Sun	
  Family	
  Learning	
  Center 2016	
  -­‐	
  2017 S  M

Matanuska-­‐Susitna  Borough  School  District Midnight  Sun  Family  Learning  Center 2016  -­‐  2017 S M

Add to Reading List

Source URL: www.midnightsunschool.com

Language: English - Date: 2016-06-23 20:55:47
412 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

Add to Reading List

Source URL: www.nzma.org.nz

Language: English - Date: 2016-07-11 21:31:12
5Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with Pancreatic or Colorectal Cancer. Kyriakos P. Papadopoulos1*, Aung Naing2*, Jeffrey R. Infante3*, Deborah J. Wong6, Karen A. Autio4, Patrick A. Ott5,

Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with Pancreatic or Colorectal Cancer. Kyriakos P. Papadopoulos1*, Aung Naing2*, Jeffrey R. Infante3*, Deborah J. Wong6, Karen A. Autio4, Patrick A. Ott5,

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2016-06-22 11:57:32
6Theranostics 2016, Vol. 6, Issue 10  Ivyspring International Publisher  Research Paper

Theranostics 2016, Vol. 6, Issue 10 Ivyspring International Publisher Research Paper

Add to Reading List

Source URL: www.thno.org

Language: English - Date: 2016-07-01 02:17:18
7Successful Generation of CAR+PD-1- Primary T Cells Using Cas9-Mediated Genome Editing G. Grant Welstead1*, Justin Fang1, Chris Nye2, Frank Buquicchio1, McKensie Collins1, Will Selleck1, Eugenio Marco1, Hari Jayaram1, Ru

Successful Generation of CAR+PD-1- Primary T Cells Using Cas9-Mediated Genome Editing G. Grant Welstead1*, Justin Fang1, Chris Nye2, Frank Buquicchio1, McKensie Collins1, Will Selleck1, Eugenio Marco1, Hari Jayaram1, Ru

Add to Reading List

Source URL: www.editasmedicine.com

Language: English - Date: 2016-08-17 16:20:25
8Safety, immune activation and anti-tumor efficacy of PEGylated recombinant human IL-10 (AM0010) Jeffrey R. Infante, MD AACR 2016 Aung Naing1, Kyriakos P. Papadopoulos2, Karen A. Autio3, Patrick A. Ott4, Manish Patel5, De

Safety, immune activation and anti-tumor efficacy of PEGylated recombinant human IL-10 (AM0010) Jeffrey R. Infante, MD AACR 2016 Aung Naing1, Kyriakos P. Papadopoulos2, Karen A. Autio3, Patrick A. Ott4, Manish Patel5, De

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2016-06-22 11:57:33
9Microsoft PowerPoint - AM0010-001 TIP Mayfinal

Microsoft PowerPoint - AM0010-001 TIP Mayfinal

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2015-12-11 00:15:27
10PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2,

PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Aung Naing1, Jeffrey R. Infante2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish R. Patel2,

Add to Reading List

Source URL: www.armobio.com

Language: English - Date: 2015-12-11 00:15:35